{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:12:26Z","timestamp":1770063146250,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ijcard.2006.03.060","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T12:46:58Z","timestamp":1155041218000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effect of peroxisome proliferator-activated receptor \u03b3 ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction"],"prefix":"10.1016","volume":"113","author":[{"given":"Deng-feng","family":"Geng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-mei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2006.03.060_bib1","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/01.LAB.0000106724.29121.DA","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, attenuates myocardial ischemia\/reperfusion injury in a rat model","volume":"83","author":"Ito","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.ijcard.2006.03.060_bib2","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1161\/hc4601.099403","article-title":"In vivo myocardial protection from ischemia\/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone","volume":"104","author":"Yue","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.03.060_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0008-6363(03)00457-7","article-title":"Peroxisome proliferation-activated receptor-\u03b3 ligands ameliorate experimental autoimmune myocarditis","volume":"59","author":"Yuan","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2006.03.060_bib4","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1042\/CS103S016S","article-title":"Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats","volume":"103","author":"Sakai","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ijcard.2006.03.060_bib5","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.RES.0000130526.20854.fa","article-title":"Inflammatory cytokines and postmyocardial infarction remodeling","volume":"94","author":"Nian","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2006.03.060_bib6","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1161\/01.CIR.0000039346.31538.2C","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor \u03b3 ligand, attenuates left ventricular remodeling and failure after experimental myocardial infarction","volume":"106","author":"Shiomi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.03.060_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjp.0705585","article-title":"Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction","volume":"141","author":"Frantz","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2006.03.060_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0008-6363(03)00289-X","article-title":"The PPARgamma-ligand rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction","volume":"58","author":"Lygate","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2006.03.060_bib9","first-page":"872","article-title":"Effects of peroxisome proliferator-activated receptor \u03b3 activator rosiglitazone on myocardial ischemic\u2013reperfusion injury in rats","volume":"21","author":"Geng","year":"2005","journal-title":"Chin J Pathophysiol (Chin)"},{"key":"10.1016\/j.ijcard.2006.03.060_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2006.03.060_bib11","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/diacare.28.7.1680","article-title":"Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project","volume":"28","author":"Inzucchi","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2006.03.060_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.48.3.609","article-title":"Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts","volume":"48","author":"Shimoyama","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2006.03.060_bib13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/sj.bjp.0704212","article-title":"Ca(2+)-sensitizing effect is involved in the positive inotropic effect of troglitazone","volume":"133","author":"Furuse","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2006.03.060_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-5273(00)00411-3","article-title":"Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients","volume":"77","author":"Hirayama","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2006.03.060_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.amjhyper.2005.02.003","article-title":"Pioglitazone improves left ventricular diastolic function in patients with essential hypertension","volume":"18","author":"Horio","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ijcard.2006.03.060_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1020696321609","article-title":"Troglitazone improves cardiac function in patients with congestive heart failure","volume":"16","author":"Ogino","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ijcard.2006.03.060_bib17","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association","volume":"108","author":"Nesto","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.03.060_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.0000154542.13412.B1","article-title":"Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study","volume":"111","author":"Masoudi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.03.060_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/00005344-200412000-00010","article-title":"Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone","volume":"44","author":"Chen","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ijcard.2006.03.060_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.HYP.0000083511.91817.B1","article-title":"Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension","volume":"42","author":"Iglarz","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.03.060_bib21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.0000144400.49062.6b","article-title":"Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone","volume":"44","author":"Chen","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.03.060_bib22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/hc1002.105225","article-title":"Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo","volume":"105","author":"Asakawa","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.03.060_bib23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/hc4001.097186","article-title":"Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes","volume":"104","author":"Yamamoto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.03.060_bib24","doi-asserted-by":"crossref","first-page":"H390","DOI":"10.1152\/ajpheart.00662.2005","article-title":"PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1","volume":"290","author":"Benkirane","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ijcard.2006.03.060_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(02)00014-X","article-title":"Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"163","author":"Fukuda","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2006.03.060_bib26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1006\/bbrc.2000.3084","article-title":"The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II","volume":"273","author":"Hattori","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijcard.2006.03.060_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-5793(99)00624-9","article-title":"Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1\/2 nuclear translocation and activation in vascular smooth muscle cells","volume":"452","author":"Goetze","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijcard.2006.03.060_bib28","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1210\/endo.142.7.8272","article-title":"Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells","volume":"142","author":"Sugawara","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2006.03.060_bib29","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.CIR.102.15.1834","article-title":"Peroxisome proliferator-activated receptor gamma ligands downregulate angiotensin II type 1 receptor in vascular smooth muscle cells","volume":"102","author":"Takeda","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.03.060_bib30","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000016049.86468.23","article-title":"Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator activated receptor-gamma","volume":"105","author":"Diep","year":"2002","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527306004463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527306004463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:17:49Z","timestamp":1759090669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527306004463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0167527306004463"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2006.03.060","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of peroxisome proliferator-activated receptor \u03b3 ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2006.03.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}